BPC-157 and TB-500 are two of the most frequently requested reference compounds in tissue-repair research. Both are studied for their roles in recovery-related signalling, but they come from different biological origins and are used to model different mechanisms.
What each compound is
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a short, 15-amino-acid sequence derived from a protective protein found in gastric juice. TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein involved in cell migration and structural regulation. Despite the different origins, both are studied in overlapping recovery and tissue-repair research contexts.
Proposed mechanisms studied
Researchers use BPC-157 primarily to study angiogenesis (new blood vessel formation) and gut-lining protection in animal models, making it a frequent reference compound in gastrointestinal and soft-tissue repair studies. TB-500 is studied mainly for its actin-binding properties — actin is a structural protein involved in cell movement — making it a common reference compound in wound-healing and cell-migration research.
Why they’re often studied together
Because their proposed mechanisms are complementary rather than overlapping (localized tissue signalling for BPC-157, cell-migration and structural repair for TB-500), the two are frequently combined in blended research formats to study potential synergistic effects on recovery models — see our peptide catalog for BPC-157/TB-500 blend listings.
Handling and storage
Both are typically supplied as a lyophilised powder and should be reconstituted with bacteriostatic water immediately before use, then stored refrigerated and protected from light. See our buyer’s checklist for quality research peptides for what to check before ordering either compound.
Frequently Asked Questions
Can BPC-157 and TB-500 be used together in research?
Yes — the two are frequently combined in blended research formats because their proposed mechanisms are considered complementary rather than overlapping.
What is the main difference between BPC-157 and TB-500?
BPC-157 is derived from a gastric-protective protein and is studied mainly for angiogenesis and gut-lining protection, while TB-500 is a Thymosin Beta-4 fragment studied mainly for actin-binding and cell-migration properties.
How should BPC-157 and TB-500 be stored?
Both are typically supplied as a lyophilised powder, reconstituted with bacteriostatic water immediately before use, and stored refrigerated and protected from light.
Are BPC-157 and TB-500 approved for human use?
No. Both are supplied strictly for laboratory research use and are not evaluated or approved for human consumption.
For laboratory research use only. Not for human consumption.